Carl Zeiss Meditec (AFX) PT Set at €48.50 by Kepler Capital Markets

Carl Zeiss Meditec (ETR:AFX) has been assigned a €48.50 ($59.88) price objective by investment analysts at Kepler Capital Markets in a research note issued to investors on Monday. The brokerage currently has a “neutral” rating on the stock. Kepler Capital Markets’ target price suggests a potential downside of 2.38% from the stock’s previous close.

A number of other equities analysts also recently issued reports on AFX. Berenberg Bank set a €55.00 ($67.90) price target on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Monday. Hauck & Aufhaeuser set a €62.50 ($77.16) price target on Carl Zeiss Meditec and gave the company a “buy” rating in a report on Thursday. Nord/LB set a €60.00 ($74.07) price target on Carl Zeiss Meditec and gave the company a “buy” rating in a report on Tuesday, December 12th. Independent Research set a €54.00 ($66.67) price target on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Friday, December 8th. Finally, set a €52.00 ($64.20) price target on Carl Zeiss Meditec and gave the company a “buy” rating in a report on Friday, November 10th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company. Carl Zeiss Meditec currently has an average rating of “Hold” and a consensus price target of €52.75 ($65.12).

Carl Zeiss Meditec (AFX) opened at €49.68 ($61.33) on Monday. The company has a market capitalization of $4,400.00 and a PE ratio of 31.64. Carl Zeiss Meditec has a 52-week low of €36.56 ($45.14) and a 52-week high of €55.25 ($68.21).

COPYRIGHT VIOLATION NOTICE: This piece of content was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at https://www.americanbankingnews.com/2018/02/12/carl-zeiss-meditec-afx-pt-set-at-48-50-by-kepler-capital-markets.html.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply